Stable coronary artery disease, quality of life, and atrial fibrillation. AVANCE study. A national survey

被引：0
|
作者：
Garcia-Moll Marimon, X. [1 ]
Borras, X. [1 ]
Gomez-Doblas, J. J. [2 ]
Zapata, A. [3 ]
Artigas, R. [3 ]
机构：
[1] Hosp Santa Creu & Sant Pau, Dept Cardiol, Barcelona, Spain
[2] Univ Hosp Virgen de la Victoria, Dept Cardiol, Malaga, Spain
[3] Menarini Spain Labs, Badalona, Spain
来源：
EUROPEAN HEART JOURNAL | 2014年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P4623
引用
收藏
页码：832 / 832
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of oral anticoagulants in elderly patients with stable coronary artery disease and atrial fibrillation
    Zhang, Xu
    Wu, Yangxun
    Lv, Chao
    Zhang, Shizhao
    Liu, Haiping
    Wang, Yuyan
    Zou, Yuting
    Qin, Liu'an
    Zhang, Junmeng
    Yin, Tong
    THROMBOSIS JOURNAL, 2022, 20 (01)
  • [42] Oral anticoagulation alone for concomitant stable coronary artery disease and atrial fibrillation: A definitive strategy?
    Rubboli, Andrea
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 264 : 95 - 96
  • [43] Atrial fibrillation in coronary artery disease: role of atrial enlargement and ischaemia
    Wang, LX
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2000, 75 (2-3) : 309 - 310
  • [44] Antiplatelet Therapy for Stable Coronary Artery Disease in Atrial Fibrillation Patients Taking an Oral Anticoagulant A Nationwide Cohort Study
    Lamberts, Morten
    Gislason, Gunnar H.
    Lip, Gregory Y. H.
    Lassen, Jens Flensted
    Olesen, Jonas Bjerring
    Mikkelsen, Anders P.
    Sorensen, Rikke
    Kober, Lars
    Torp-Pedersen, Christian
    Hansen, Morten Lock
    CIRCULATION, 2014, 129 (15) : 1577 - 1585
  • [45] Improving risk stratification in atrial fibrillation: Renal dysfunction and risk of thromboembolism and death in nonvalvular atrial fibrillation. The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study.
    Go, AS
    Hylek, EM
    Udaltsova, N
    Chang, YC
    Jensvold, NG
    Henault, LE
    Singer, DE
    CIRCULATION, 2004, 109 (07) : E92 - E92
  • [46] Antithrombotic Therapy for Atrial Fibrillation and stable coronary Heart Disease
    Dovjak, Peter
    ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2019, 52 (08): : 808 - 809
  • [47] Incidence and outcome of atrial fibrillation in stable symptomatic coronary disease
    Otterstad, Jan Erik
    Kirwan, Bridget-Anne
    Lubsen, Jacobus
    De Brouwer, Sophie
    Fox, Keith A. A.
    Corell, Pernille
    Poole-Wilson, Philip A.
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2006, 40 (03) : 152 - 159
  • [48] Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease REPLY
    Yasuda, Satoshi
    Ogawa, Hisao
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (25): : 2481 - 2481
  • [49] Correlates and outcome of atrial fibrillation in stable symptomatic coronary disease
    Otterstad, J. E.
    Kirwan, B. -A.
    Lubsen, J.
    De Brouwer, S.
    Fox, K. A. A.
    Hildebrandt, P.
    Poole-Wilson, P. A.
    EUROPEAN HEART JOURNAL, 2006, 27 : 882 - 882
  • [50] Assessment of Economic Burden and Quality of Life in Stable Coronary Artery Disease Patients
    Kumar, Lalit
    Prakash, Anupam
    Gupta, S. K.
    INDIAN JOURNAL OF MEDICAL SPECIALITIES, 2019, 10 (01) : 26 - 29
12345